-
Compound Developed by Johns Hopkins Shown to Slow Parkinson’s Progression in Mouse Study
An investigative compound similar to those used to treat diabetes was able to slow Parkinson’s progression and ease behavioral symptoms in a mouse model of Parkinson’s disease, researchers at Johns Hopkins report. The study, “Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease,” was published in Nature Medicine.
Click here to read a summary of the findings.
What are your thoughts on this news?
Sorry, there were no replies found.
Log in to reply.